The Patent Finder

Cellivery Therapeutics, Inc.

Also on record
Records under this name other than the patents Cellivery Therapeutics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 10 patents it holds.

Showing 1 to 4 of 4 · Back to Cellivery Therapeutics, Inc.

PatentTitleStatus Expires Confidence
US 11,319,546Cell-Permeable (CP)-CAS9 Recombinant Protein and Uses Thereof
Lapsed on the fee record
Ended May 3, 2026 · High confidence
Lapsed on the fee recordEnded May 3, 2026High confidence
US 11,279,743Cell-Permeable Bone Morphogenetic Protein (CPBMP) Recombinant Protein and Use Thereof
Lapsed on the fee record
Ended Mar 22, 2026 · High confidence
Lapsed on the fee recordEnded Mar 22, 2026High confidence
US 10,975,132Cell-Permeable (ICP)-SOCS3 Recombinant Protein and Uses Thereof
Lapsed on the fee record
Ended Apr 13, 2025 · High confidence
Lapsed on the fee recordEnded Apr 13, 2025High confidence
US 10,961,292Cell-Permeable (ICP)-SOCS3 Recombinant Protein and Uses Thereof
Lapsed on the fee record
Ended Mar 30, 2025 · High confidence
Lapsed on the fee recordEnded Mar 30, 2025High confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited